Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Envoy Medical (COCH) Invested Capital (2021 - 2026)

Envoy Medical's Invested Capital history spans 6 years, with the latest figure at $10.2 million for Q1 2026.

  • On a quarterly basis, Invested Capital rose 141.95% to $10.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was $10.2 million, a 141.95% increase, with the full-year FY2025 number at -$12.2 million, up 35.47% from a year prior.
  • Invested Capital hit $10.2 million in Q1 2026 for Envoy Medical, up from -$12.2 million in the prior quarter.
  • Over the last five years, Invested Capital for COCH hit a ceiling of $10.2 million in Q1 2026 and a floor of -$47.5 million in Q1 2023.
  • Historically, Invested Capital has averaged -$19.0 million across 5 years, with a median of -$18.8 million in 2024.
  • Biggest five-year swings in Invested Capital: crashed 1186.14% in 2024 and later skyrocketed 141.95% in 2026.
  • Tracing COCH's Invested Capital over 5 years: stood at -$35.9 million in 2022, then skyrocketed by 95.91% to -$1.5 million in 2023, then crashed by 1186.14% to -$18.8 million in 2024, then soared by 35.47% to -$12.2 million in 2025, then soared by 183.57% to $10.2 million in 2026.
  • Business Quant data shows Invested Capital for COCH at $10.2 million in Q1 2026, -$12.2 million in Q4 2025, and -$7.7 million in Q3 2025.